April 17, 2026

Cure On Time

Make Health a Lifestyle

Fungal biofilms in human health and disease

Fungal biofilms in human health and disease
  • Camara, M. et al. Economic significance of biofilms: a multidisciplinary and cross-sectoral challenge. NPJ Biofilms Microbiomes 8, 42 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Marrie, T. J. & Costerton, J. W. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J. Clin. Microbiol. 19, 687–693 (1984).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Denning, D. W. Global incidence and mortality of severe fungal disease. Lancet Infect. Dis. 24, e428–e438 (2024). This work presents a comprehensive literature analysis of an updated global burden of fungal diseases.

    Article 
    PubMed 

    Google Scholar 

  • World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. WHO (2022).

  • Ramage, G. et al. Our current clinical understanding of Candida biofilms: where are we two decades on? APMIS 131, 636–653 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Donlan, R. M. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8, 881–890 (2002).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rumbaugh, K. P. & Bjarnsholt, T. Microbial primer: in vivo biofilm. Microbiology 169, 001407 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Nett, J. et al. Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51, 510–520 (2007). This pioneering study identifies the function for β-glucans in conferring biofilm tolerance in the ECM.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Sauer, K. et al. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat. Rev. Microbiol. 20, 608–620 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Williams, C. & Ramage, G. Fungal biofilms in human disease. Adv. Exp. Med. Biol. 831, 11–27 (2015).

    Article 
    PubMed 

    Google Scholar 

  • Robey, A. B. et al. The changing face of paranasal sinus fungus balls. Ann. Otol. Rhinol. Laryngol. 118, 500–505 (2009).

    Article 
    PubMed 

    Google Scholar 

  • Nguyen, U. T. & Kalan, L. R. Forgotten fungi: the importance of the skin mycobiome. Curr. Opin. Microbiol. 70, 102235 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kalan, L. & Grice, E. A. Fungi in the wound microbiome. Adv. Wound Care 7, 247–255 (2018).

    Article 

    Google Scholar 

  • Benedict, K., Jackson, B. R., Chiller, T. & Beer, K. D. Estimation of direct healthcare costs of fungal diseases in the United States. Clin. Infect. Dis. 68, 1791–1797 (2019).

    Article 
    PubMed 

    Google Scholar 

  • Ramage, G. et al. in Antibiofilm Strategies: Current and Future Applications to Prevent, Control and Eradicate Biofilms (eds Richter, K. & Kragh, K. N.) 441–465 (Springer, 2022).

  • Coco, B. J. et al. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral. Microbiol. Immunol. 23, 377–383 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Parahitiyawa, N. B. et al. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 114, 298–306 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nett, J. E., Cain, M. T., Crawford, K. & Andes, D. R. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J. Clin. Microbiol. 49, 1426–1433 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Budtz-Jorgensen, E. The significance of Candida albicans in denture stomatitis. Scand. J. Dent. Res. 82, 151–190 (1974).

    CAS 
    PubMed 

    Google Scholar 

  • Ramage, G., Tomsett, K., Wickes, B. L., Lopez-Ribot, J. L. & Redding, S. W. Denture stomatitis: a role for Candida biofilms. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 98, 53–59 (2004).

    Article 
    PubMed 

    Google Scholar 

  • Fujinami, W., Nishikawa, K., Ozawa, S., Hasegawa, Y. & Takebe, J. Correlation between the relative abundance of oral bacteria and Candida albicans in denture and dental plaques. J. Oral. Biosci. 63, 175–183 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • O’Donnell, L. E. et al. The oral microbiome of denture wearers is influenced by levels of natural dentition. PLoS ONE 10, e0137717 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Redfern, J. et al. The denture microbiome in health and disease: an exploration of a unique community. Lett. Appl. Microbiol. 75, 195–209 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Eidt, G., Waltermann, E. D. M., Hilgert, J. B. & Arthur, R. A. Candida and dental caries in children, adolescents and adults: a systematic review and meta-analysis. Arch. Oral. Biol. 119, 104876 (2020).

    Article 
    PubMed 

    Google Scholar 

  • Slazhneva, E. et al. Candida species detection in patients with chronic periodontitis: a systematic review and meta-analysis. Clin. Exp. Dent. Res. 8, 1354–1375 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Delliere, S. et al. Analysis of microbiota and mycobiota in fungal ball rhinosinusitis: specific interaction between Aspergillus fumigatus and Haemophilus influenza? J. Fungi. (2021).

  • Hashemi, S. J. et al. A case of fungus ball-type pansinusitis due to Fusarium proliferatum. Mycopathologia 180, 251–255 (2015).

    Article 
    PubMed 

    Google Scholar 

  • Lee, J. T. et al. Fungal and bacterial microbiome in sinus mucosa of patients with and without chronic rhinosinusitis. Laryngoscope 134, 1054–1062 (2024).

    Article 
    PubMed 

    Google Scholar 

  • Nambiar, M. et al. Mycotic infections—mucormycosis and oral candidiasis associated with COVID-19: a significant and challenging association. J. Oral. Microbiol. 13, 1967699 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Roh, D. et al. Sinonasal microbiome and inflammatory profiles in fungal ball and chronic rhinosinusitis. Auris Nasus Larynx 51, 242–250 (2024).

    Article 
    PubMed 

    Google Scholar 

  • Martin, T. J., Kerschner, J. E. & Flanary, V. A. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int. J. Pediatr. Otorhinolaryngol. 69, 1503–1508 (2005).

    Article 
    PubMed 

    Google Scholar 

  • Zhang, X., Sun, X., Wang, Z., Zhang, Y. & Hou, W. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Invest. Ophthalmol. Vis. Sci. 53, 7774–7778 (2012).

    Article 
    PubMed 

    Google Scholar 

  • Muni, I., Behera, H. S., Sahu, S. K., Priyadarshini, S. R. & Das, S. Microbiological profile of culture-positive fungal keratitis. Eye Contact Lens (2024).

  • Abdulkareem, A. F., Lee, H. H., Ahmadi, M. & Martinez, L. R. Fungal serotype-specific differences in bacterial–yeast interactions. Virulence 6, 652–657 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Aslanyan, L. et al. The crucial role of biofilms in Cryptococcus neoformans survival within macrophages and colonization of the central nervous system. J. Fungi. (2017).

  • Kolpen, M. et al. Bacterial biofilms predominate in both acute and chronic human lung infections. Thorax 77, 1015–1022 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Hong, G. et al. Distinct community structures of the fungal microbiome and respiratory health in adults with cystic fibrosis. J. Cyst. Fibros. 22, 636–643 (2023).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cuthbertson, L. et al. The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis. J. Cyst. Fibros. 20, 295–302 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Amin, R., Dupuis, A., Aaron, S. D. & Ratjen, F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137, 171–176 (2010).

    Article 
    PubMed 

    Google Scholar 

  • Kean, R. et al. Candida albicans mycofilms support Staphylococcus aureus colonization and enhances miconazole resistance in dual-species interactions. Front. Microbiol. 8, 258 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sobel, J. D. Editorial commentary: Vaginal biofilm: much ado about nothing, or a new therapeutic challenge? Clin. Infect. Dis. 61, 607–608 (2015).

    Article 
    PubMed 

    Google Scholar 

  • Wu, X. et al. Biofilm formation of Candida albicans facilitates fungal infiltration and persister cell formation in vaginal candidiasis. Front Microbiol 11, 1117 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • McKloud, E. et al. Recurrent vulvovaginal candidiasis: a dynamic interkingdom biofilm disease of Candida and Lactobacillus. mSystems 6, e0062221 (2021).

    Article 
    PubMed 

    Google Scholar 

  • Pan, Y. et al. Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium. Biofilm 6, 100162 (2023). This paper elegantly demonstrates that Candida is able to form biofilms on vaginal mucosa, a continued area of contention that impacts antifungal management.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bumroongthai, K., Chetanachan, P., Niyomtham, W., Yurayart, C. & Prapasarakul, N. Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis. Med Mycol. 54, 544–549 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Markantonatou, A. M., Samaras, K. & Vyzantiadis, T. A. Dermatophytic biofilms: characteristics, significance and treatment approaches. J. Fungi. (2023).

  • Chellan, G. et al. Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes. J. Clin. Microbiol. 48, 2097–2102 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Dowd, S. E. et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J. Wound Care 20, 40–47 (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Short, B. et al. in Current Clinical Microbiology Reports Vol. 10 (ed. Diezmann, S.) 9–16 (Springer Link, 2023).

  • Bharti, S., Zakir, F., Mirza, M. A. & Aggarwal, G. Antifungal biofilm strategies: a less explored area in wound management. Curr. Pharm. Biotechnol. 23, 1497–1513 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Sansom, S. E. et al. Rapid environmental contamination with Candida auris and multidrug-resistant bacterial pathogens near colonized patients. Clin. Infect. Dis. 78, 1276–1284 (2024).

    Article 
    PubMed 

    Google Scholar 

  • Arciola, C. R., Campoccia, D. & Montanaro, L. Implant infections: adhesion, biofilm formation and immune evasion. Nat. Rev. Microbiol. 16, 397–409 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • O’Donnell, L. E. et al. Dentures are a reservoir for respiratory pathogens. J. Prosthodont. 25, 99–104 (2016).

    Article 
    PubMed 

    Google Scholar 

  • van Charante, F. et al. Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients. Biofilm 4, 100079 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Baidya, S. et al. Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital: an armor for refuge. Biomed. Res Int 2021, 8817700 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Velasquez-Garcia, L., Mejia-Sanjuanelo, A., Viasus, D. & Carratala, J. Causative agents of ventilator-associated pneumonia and resistance to antibiotics in COVID-19 patients: a systematic review. Biomedicines (2022).

  • Cetinkaya, E. et al. Simultaneous chronic invasive fungal infection and tracheal fungus ball mimicking cancer in an immunocompetent patient. Case Rep. Med. 2016, 2416452 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • McGinniss, J. E. et al. Molecular analysis of the endobronchial stent microbial biofilm reveals bacterial communities that associate with stent material and frequent fungal constituents. PLoS ONE 14, e0217306 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Huang, D., Qi, M., Hu, Y., Yu, M. & Liang, Z. The impact of Candida spp airway colonization on clinical outcomes in patients with ventilator-associated pneumonia: a systematic review and meta-analysis. Am. J. Infect. Control 48, 695–701 (2020).

    Article 
    PubMed 

    Google Scholar 

  • Durliat, A., Locatelli-Sanchez, M., Wallet, F. & Allaouchiche, B. Tracheal stent aspergillosis occurring after aortic allograft of the trachea. Transpl. Infect. Dis. 24, e13965 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Tumbarello, M. et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45, 1843–1850 (2007).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Walsh, T. J., Schlegel, R., Moody, M. M., Costerton, J. W. & Salcman, M. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18, 373–375 (1986).

    CAS 
    PubMed 

    Google Scholar 

  • Rajendran, R. et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013. Clin. Microbiol. Infect. 22, 87–93 (2016). This paper is one of the first to demonstrate that different levels of biofilm formation correlate with clinical outcomes.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rajendran, R. et al. A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol 7, 915 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62, e1–e50 (2016).

    Article 
    PubMed 

    Google Scholar 

  • McGhee, W., Michaels, M. G., Martin, J. M., Mazariegos, G. V. & Green, M. Antifungal lock therapy with liposomal amphotericin B: a prospective trial. J. Pediatr. Infect. Dis. Soc. 5, 80–84 (2016).

    Article 

    Google Scholar 

  • Paul DiMondi, V., Townsend, M. L., Johnson, M. & Durkin, M. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis. Pharmacotherapy 34, e120–e127 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Walraven, C. J. & Lee, S. A. Antifungal lock therapy. Antimicrob. Agents Chemother. 57, 1–8 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Di Benedetto, G. et al. Giant Candida mycetoma in an ascending aorta tubular graft. J. Card. Surg. 28, 557–560 (2013).

    Article 
    PubMed 

    Google Scholar 

  • Hebert, J., Barr, E. & Magee, C. Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient. BMJ Case Rep. (2021).

  • Herndon, C. L. et al. Treatment outcomes of fungal periprosthetic joint infection. J. Arthroplast. 38, 2436–2440.e1 (2023).

    Article 

    Google Scholar 

  • Diop, S. et al. Biofilm assessment and metagenomic analysis of venoarterial extracorporeal membrane oxygenation cannulas and membrane oxygenators. ASAIO J. 70, 199–206 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Eyre, D. W. et al. A Candida auris outbreak and its control in an intensive care setting. N. Engl. J. Med. 379, 1322–1331 (2018). This paper demonstrates that C. auris is capable of persisting on surfaces outwith the human body to aid transmission.

    Article 
    PubMed 

    Google Scholar 

  • Biswal, M. et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J. Hosp. Infect. 97, 363–370 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Weber, D. J., Rutala, W. A., Anderson, D. J. & Sickbert-Bennett, E. E. Biofilms on medical instruments and surfaces: do they interfere with instrument reprocessing and surface disinfection. Am. J. Infect. Control. 51, A114–A119 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Lohse, M. B., Gulati, M., Johnson, A. D. & Nobile, C. J. Development and regulation of single- and multi-species Candida albicans biofilms. Nat. Rev. Microbiol. 16, 19–31 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Ajesh, K. & Sreejith, K. Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance. Mycopathologia 174, 409–419 (2012).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Fox, E. P. et al. An expanded regulatory network temporally controls Candida albicans biofilm formation. Mol. Microbiol. 96, 1226–1239 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Harding, M. W., Marques, L. L., Howard, R. J. & Olson, M. E. Can filamentous fungi form biofilms? Trends Microbiol. 17, 475–480 (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kean, R. et al. Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere (2018).

  • Laffey, S. F. & Butler, G. Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology 151, 1073–1081 (2005).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Lopes, W. et al. Geometrical distribution of Cryptococcus neoformans mediates flower-like biofilm development. Front. Microbiol. 8, 2534 (2017). This paper elegantly shows that C. neoformans is capable of forming defined biofilm structures that aid development and dispersal.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Malinovska, Z., Conkova, E. & Vaczi, P. Biofilm formation in medically important Candida species. J. Fungi. (2023).

  • Morelli, K. A., Kerkaert, J. D. & Cramer, R. A. Aspergillus fumigatus biofilms: toward understanding how growth as a multicellular network increases antifungal resistance and disease progression. PLoS Pathog. 17, e1009794 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ravi, S., Pierce, C., Witt, C. & Wormley, F. L. Jr. Biofilm formation by Cryptococcus neoformans under distinct environmental conditions. Mycopathologia 167, 307–314 (2009).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Scherer, A. K. et al. Redundant Trojan horse and endothelial-circulatory mechanisms for host-mediated spread of Candida albicans yeast. PLoS Pathog. 16, e1008414 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sephton-Clark, P. C. S. & Voelz, K. Spore germination of pathogenic filamentous fungi. Adv. Appl. Microbiol. 102, 117–157 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Silva, S. et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 36, 288–305 (2012).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wang, T.W. et al. Functional redundancy in Candida auris cell surface adhesins crucial for cell-cell interaction and aggregation. Nat. Commun. 15, 9212 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cota, E. & Hoyer, L. L. The Candida albicans agglutinin-like sequence family of adhesins: functional insights gained from structural analysis. Future Microbiol. 10, 1635–1548 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Dutton, L. C. et al. Transcriptional landscape of trans-kingdom communication between Candida albicans and Streptococcus gordonii. Mol. Oral. Microbiol. 31, 136–161 (2016). This study demonstrates the specific adhesion and interaction between yeasts and bacteria, indicating common partnerships in complex environments.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Sundstrom, P. Adhesion in Candida spp. Cell Microbiol. 4, 461–469 (2002).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Golan, N., Schwartz-Perov, S., Landau, M. & Lipke, P. N. Structure and conservation of amyloid spines from the Candida albicans Als5 adhesin. Front. Mol. Biosci. 9, 926959 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lipke, P. N., Klotz, S. A., Dufrene, Y. F., Jackson, D. N. & Garcia-Sherman, M. C. Amyloid-like β-aggregates as force-sensitive switches in fungal biofilms and infections. Microbiol. Mol. Biol. Rev. (2018).

  • Timmermans, B., De Las Penas, A., Castano, I. & Van Dijck, P. Adhesins in Candida glabrata. J. Fungi. (2018).

  • Dague, E., Alsteens, D., Latge, J. P. & Dufrene, Y. F. High-resolution cell surface dynamics of germinating Aspergillus fumigatus conidia. Biophys. J. 94, 656–660 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Upadhyay, S. K. et al. Identification and characterization of a laminin-binding protein of Aspergillus fumigatus: extracellular thaumatin domain protein (AfCalAp). J. Med. Microbiol. 58, 714–722 (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Liu, H. et al. Aspergillus fumigatus CalA binds to integrin ɑ5β1 and mediates host cell invasion. Nat. Microbiol. 2, 16211 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Martinez, L. R. & Casadevall, A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect. Immun. 73, 6350–6362 (2005).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gonzalez-Ramirez, A. I., Ramirez-Granillo, A., Medina-Canales, M. G., Rodriguez-Tovar, A. V. & Martinez-Rivera, M. A. Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy. BMC Microbiol. 16, 243 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Nobile, C. J. et al. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18, 1017–1024 (2008). This study identifies the first core regulatory transcriptional network in C. albicans.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bing, J. et al. Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4. PLoS Pathog. 19, e1011239 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Santana, D. J. et al. A Candida auris-specific adhesin, Scf1, governs surface association, colonization, and virulence. Science 381, 1461–1467 (2023). This study categorizes the function of a novel C. auris specific adhesin, Scf1, in relation to colonization, biofilm formation and virulence.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Martinez, L. R. & Casadevall, A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50, 1021–1033 (2006).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kowalski, C. H. et al. Fungal biofilm morphology impacts hypoxia fitness and disease progression. Nat. Microbiol. 4, 2430–2441 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kowalski, C. H., Morelli, K. A., Stajich, J. E., Nadell, C. D. & Cramer, R. A. A heterogeneously expressed gene family modulates the biofilm architecture and hypoxic growth of Aspergillus fumigatus. mBio (2021).

  • Pentland, D. R., Davis, J., Muhlschlegel, F. A. & Gourlay, C. W. CO2 enhances the formation, nutrient scavenging and drug resistance properties of C. albicans biofilms. NPJ Biofilms Microbiomes 7, 67 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rossignol, T. et al. Correlation between biofilm formation and the hypoxic response in Candida parapsilosis. Eukaryot. Cell 8, 550–559 (2009).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pierce, C. G. et al. The Candida albicans biofilm matrix: composition, structure and function. J. Fungi. (2017).

  • Zarnowski, R. et al. A common vesicle proteome drives fungal biofilm development. Proc. Natl Acad. Sci. USA 119, e2211424119 (2022). This study identifies a conserved component across the extracellular vesicle proteome of biofilms formed by various Candida spp.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kong, E. F. et al. Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. mBio 7, e01365-16 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Uppuluri, P. et al. Candida albicans dispersed cells are developmentally distinct from biofilm and planktonic cells. mBio (2018).

  • Uppuluri, P. et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 6, e1000828 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Nobile, C. J. & Mitchell, A. P. Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol. 8, 1382–1391 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kumamoto, C. A. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc. Natl Acad. Sci. USA 102, 5576–5581 (2005).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Blankenship, J. R. & Mitchell, A. P. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9, 588–594 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nobile, C. J. & Mitchell, A. P. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15, 1150–1155 (2005).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nobile, C. J. et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148, 126–138 (2012).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu, S., Le Mauff, F., Sheppard, D. C. & Zhang, S. Filamentous fungal biofilms: conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus. NPJ Biofilms Microbiomes 8, 83 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Subroto, E., van Neer, J., Valdes, I. & de Cock, H. Growth of Aspergillus fumigatus in biofilms in comparison to Candida albicans. J. Fungi. (2022).

  • Bom, V. L. et al. The Aspergillus fumigatus sitA phosphatase homologue is important for adhesion, cell wall integrity, biofilm formation, and virulence. Eukaryot. Cell 14, 728–744 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lin, C. J., Hou, Y. H. & Chen, Y. L. The histone acetyltransferase GcnE regulates conidiation and biofilm formation in Aspergillus fumigatus. Med. Mycol. 58, 248–259 (2020).

    CAS 
    PubMed 

    Google Scholar 

  • Robbins, N. et al. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 7, e1002257 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Granger, B. L. Insight into the antiadhesive effect of yeast wall protein 1 of Candida albicans. Eukaryot. Cell 11, 795–805 (2012).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • McCall, A. D., Pathirana, R. U., Prabhakar, A., Cullen, P. J. & Edgerton, M. Author correction: Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins. NPJ Biofilms Microbiomes 7, 91 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Baillie, G. S. & Douglas, L. J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46, 397–403 (2000).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nett, J. E., Sanchez, H., Cain, M. T. & Andes, D. R. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202, 171–175 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Rajendran, R. et al. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot. Cell 12, 420–429 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zarnowski, R. et al. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 16, e2006872 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rizzo, J. et al. Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans. mBio 14, e0087023 (2023).

    Article 
    PubMed 

    Google Scholar 

  • Bitencourt, T. A. et al. Fungal extracellular vesicles are involved in intraspecies intracellular communication. mBio 13, e0327221 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Wuyts, J., Van Dijck, P. & Holtappels, M. Fungal persister cells: the basis for recalcitrant infections? PLoS Pathog. 14, e1007301 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rossoni, R. D. et al. The postbiotic activity of Lactobacillus paracasei 28.4 against Candida auris. Front. Cell Infect. Microbiol. 10, 397 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bink, A. et al. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 55, 4033–4037 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Diezmann, S., Leach, M. D. & Cowen, L. E. Functional divergence of Hsp90 genetic interactions in biofilm and planktonic cellular states. PLoS One 10, e0137947 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Denega, I., d’Enfert, C. & Bachellier-Bassi, S. Candida albicans biofilms are generally devoid of persister cells. Antimicrob. Agents Chemother. (2019).

  • Fux, C. A., Shirtliff, M., Stoodley, P. & Costerton, J. W. Can laboratory reference strains mirror “real-world” pathogenesis? Trends Microbiol. 13, 58–63 (2005).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Glazier, V. E. et al. The Candida albicans reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates filamentation, biofilm formation, and oral commensalism. mBio 14, e0152123 (2023).

    Article 
    PubMed 

    Google Scholar 

  • Wakade, R. S., Huang, M., Mitchell, A. P., Wellington, M. & Krysan, D. J. Intravital imaging of Candida albicans identifies differential in vitro and in vivo filamentation phenotypes for transcription factor deletion mutants. mSphere 6, e0043621 (2021).

    Article 
    PubMed 

    Google Scholar 

  • Huang, M. Y., Woolford, C. A., May, G., McManus, C. J. & Mitchell, A. P. Circuit diversification in a biofilm regulatory network. PLoS Pathog. 15, e1007787 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cravener, M. V. et al. Reinforcement amid genetic diversity in the Candida albicans biofilm regulatory network. PLoS Pathog. 19, e1011109 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Delaney, C. et al. An integrated transcriptomic and metabolomic approach to investigate the heterogeneous Candida albicans biofilm phenotype. Biofilm 5, 100112 (2023).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rajendran, R. et al. Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Sci. Rep. 6, 35436 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Holland, L. M. et al. Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicans. PLoS Pathog. 10, e1004365 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ramage, G., Rajendran, R., Sherry, L. & Williams, C. Fungal biofilm resistance. Int. J. Microbiol. 2012, 528521 (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46, 1773–1780 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bachmann, S. P. et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46, 3591–3596 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bachmann, S. P., Patterson, T. F. & Lopez-Ribot, J. L. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J. Clin. Microbiol. 40, 2228–2230 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jacobson, M. J., Steckelberg, K. E., Piper, K. E., Steckelberg, J. M. & Patel, R. In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrob. Agents Chemother. 53, 2638–2639 (2009).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jacobson, M. J., Piper, K. E., Nguyen, G., Steckelberg, J. M. & Patel, R. In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 52, 2242–2243 (2008).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Carolus, H., Pierson, S., Lagrou, K. & Van Dijck, P. Amphotericin B and other polyenes—discovery, clinical use, mode of action and drug resistance. J. Fungi. (2020).

  • Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A. & Jin, L. Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters. Antimicrob. Agents Chemother. 59, 6101–6112 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sigera, L. S. M. & Denning, D. W. Flucytosine and its clinical usage. Ther. Adv. Infect. Dis. 10, 20499361231161387 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hoenigl, M. et al. The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs 81, 1703–1729 (2021). This comprehensive review provides a detailed overview of the new pipeline of antifungal drugs.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Neoh, C. F., Jeong, W., Kong, D. C. & Slavin, M. A. The antifungal pipeline for invasive fungal diseases: what does the future hold? Expert. Rev. Anti Infect. Ther. 21, 577–594 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Lanier, C. & Melton, T. C. Oteseconazole for the treatment of recurrent vulvovaginal candidiasis: a drug review. Ann. Pharmacother. 58, 636–644 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Michael, M. The FDA approves new antifungal oteseconazole. Chemical & Engineering News (2022).

  • Sobel, J. D. et al. Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis. NEJM Evid. 1, EVIDoa2100055 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Wiederhold, N. P. Pharmacodynamics, mechanisms of action and resistance, and spectrum of activity of new antifungal agents. J. Fungi 8, 857 (2022).

    Article 
    CAS 

    Google Scholar 

  • Wiederhold, N. P. et al. Ibrexafungerp demonstrates in vitro activity against fluconazole-resistant Candida auris and in vivo efficacy with delayed initiation of therapy in an experimental model of invasive Candidiasis. Antimicrob. Agents Chemother. 65, e02694–02620 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Larkin, E. et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob. Agents Chemother. (2017).

  • Marcos-Zambrano, L. J., Gomez-Perosanz, M., Escribano, P., Bouza, E. & Guinea, J. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp. J. Antimicrob. Chemother. 72, 1969–1976 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • He, R., Lin, F., Yu, B. & Huang, L. Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: a meta-analysis of randomized controlled trials. Heliyon 10, e28776 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Locke, J. B. et al. Outcomes by Candida spp. in the ReSTORE phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrob. Agents Chemother. 68, e0158423 (2024).

    Article 
    PubMed 

    Google Scholar 

  • Thompson, G. R. 3rd et al. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. Lancet Infect. Dis. 24, 319–328 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Chandra, J. & Ghannoum, M. A. CD101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms. Antimicrob. Agents Chemother. (2018).

  • US National Library of Medicine. ClinicalTrials.gov (2024).

  • Shaw, K. J. & Ibrahim, A. S. Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections. J. Fungi. 6, 239 (2020).

    Article 
    CAS 

    Google Scholar 

  • Watanabe, N. A. et al. E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Antimicrob. Agents Chemother. 56, 960–971 (2012).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kriegl, L., Egger, M., Boyer, J., Hoenigl, M. & Krause, R. New treatment options for critically important WHO fungal priority pathogens. Clin. Microbiol. Infect. (2024).

  • Borba-Santos, L. P. et al. Screening of pandemic response box library reveals the high activity of olorofim against pathogenic sporothrix species. J. Fungi. (2022).

  • Kirchhoff, L. et al. Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim. J. Antimicrob. Chemother. 77, 1645–1654 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wall, G., Chen, E., Hull, M. V. & Lopez-Ribot, J. L. Screening the CALIBR ReFRAME library in search for inhibitors of Candida auris biofilm formation. Front. Cell Infect. Microbiol. 10, 597931 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wall, G. & Lopez-Ribot, J. L. Screening repurposing libraries for identification of drugs with novel antifungal activity. Antimicrob. Agents Chemother. (2020).

  • Ajetunmobi, O. H. et al. High-throughput screening of the repurposing hub library to identify drugs with novel inhibitory activity against Candida albicans and Candida auris biofilms. J. Fungi. (2023).

  • Zhao, M. et al. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking. J. Clin. Invest. (2021). This study identifies turbinmicin as a novel extracellular vesicle-targeting antifungal.

  • Guha, S. et al. Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. mBio 15, e0057024 (2024).

    Article 
    PubMed 

    Google Scholar 

  • AlJindan, R. & AlEraky, D. M. Silver nanoparticles: a promising antifungal agent against the growth and biofilm formation of the emergent Candida auris. J. Fungi. (2022).

  • Miyazima, T. Y., Ishikawa, K. H., Mayer, M. P. A., Saad, S. M. I. & Nakamae, A. E. M. Cheese supplemented with probiotics reduced the Candida levels in denture wearers—RCT. Oral. Dis. 23, 919–925 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Chakrabarti, A. et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 119, 1809–1818 (2009).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Mello, T. P., Lackner, M., Branquinha, M. H. & Santos, A. L. S. Impact of biofilm formation and azoles’ susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients’ airway environment. J. Cyst. Fibros. 20, 303–309 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Parize, P. et al. Outcome of patients with cystic fibrosis colonized by Scedosporium and Lomentospora species: a longitudinal cohort study. Med. Mycol. (2023).

  • Grimshaw, S. G. et al. The diversity and abundance of fungi and bacteria on the healthy and dandruff affected human scalp. PLoS ONE 14, e0225796 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ghannoum, M. & Isham, N. Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog. 10, e1004105 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pinto, H., Simoes, M. & Borges, A. Prevalence and impact of biofilms on bloodstream and urinary tract infections: a systematic review and meta-analysis. Antibiotics (2021).

  • Miesel, L., Cushion Melanie, T., Ashbaugh, A., Lopez Santiago, R. & Ong, V. Efficacy of rezafungin in prophylactic mouse models of invasive candidiasis, aspergillosis, and pneumocystis pneumonia. Antimicrob. Agents Chemother. 65, e01992-20 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Goje, O. et al. Oral ibrexafungerp for vulvovaginal candidiasis treatment: an analysis of VANISH 303 and VANISH 306. J. Women’s Health 32, 178–186 (2023).

    Article 

    Google Scholar 

  • Kirchhoff, L. et al. Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans. J. Antimicrob. Chemother. 75, 2133–2140 (2020).

    CAS 
    PubMed 

    Google Scholar 

  • Gintjee, T. J., Donnelley, M. A. & Thompson, G. R., III. Aspiring antifungals: review of current antifungal pipeline developments. J. Fungi. (2020).

  • Kean, R. & Ramage, G. Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris. mSphere (2019).

  • Martinez, L. R. & Casadevall, A. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl. Environ. Microbiol. 73, 4592–4601 (2007).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Williams, C., Rajendran, R. & Ramage, G. Aspergillus biofilms in human disease. Adv. Exp. Med. Biol. 931, 1–11 (2016).

    Article 
    PubMed 

    Google Scholar 

  • Hoyer, L. L. & Cota, E. Candida albicans agglutinin-like sequence (Als) family vignettes: a review of Als protein structure and function. Front. Microbiol. 7, 280 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ramage, G., VandeWalle, K., Lopez-Ribot, J. L. & Wickes, B. L. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214, 95–100 (2002).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Dominguez, E. et al. Conservation and divergence in the Candida species biofilm matrix mannan–glucan complex structure, function, and genetic control. mBio (2018).

  • Nobile, C. J. et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 7, e1000133 (2009).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Dominguez, E. G. et al. Conserved role for biofilm matrix polysaccharides in Candida auris drug resistance. mSphere (2019).

  • Bottcher, B. et al. A highly conserved tRNA modification contributes to C. albicans filamentation and virulence. Microbiol. Spectr. 12, e0425522 (2024).

    Article 
    PubMed 

    Google Scholar 

  • Gravelat, F. N. et al. Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence. Cell Microbiol. 12, 473–488 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Rajendran, R. et al. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob. Agents Chemother. 55, 2092–2097 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang, L., Tian, X., Gyawali, R. & Lin, X. Fungal adhesion protein guides community behaviors and autoinduction in a paracrine manner. Proc. Natl Acad. Sci. USA 110, 11571–11576 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ramage, G. Comparing apples and oranges: considerations for quantifying candidal biofilms with XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] and the need for standardized testing. J. Med. Microbiol. 65, 259–260 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • link

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Copyright © All rights reserved. | Newsphere by AF themes.